The Chemours Company (NYSE:CC) Receives $21.56 Consensus Target Price from Analysts

Shares of The Chemours Company (NYSE:CC - Get Free Report) have received a consensus rating of "Moderate Buy" from the nine research firms that are covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $21.56.

CC has been the topic of a number of analyst reports. Mizuho set a $15.00 price objective on shares of Chemours in a research note on Tuesday, April 15th. The Goldman Sachs Group cut their target price on Chemours from $24.00 to $21.00 and set a "neutral" rating for the company in a research note on Tuesday, January 7th. Morgan Stanley decreased their price target on Chemours from $25.00 to $22.00 and set an "equal weight" rating on the stock in a research note on Monday, January 13th. Barclays dropped their price objective on Chemours from $19.00 to $16.00 and set an "equal weight" rating for the company in a research report on Tuesday, April 1st. Finally, Truist Financial lowered their target price on Chemours from $27.00 to $22.00 and set a "buy" rating for the company in a research note on Monday, April 14th.

Institutional Investors Weigh In On Chemours

Institutional investors have recently made changes to their positions in the stock. Barclays PLC lifted its position in shares of Chemours by 28.4% in the 3rd quarter. Barclays PLC now owns 107,549 shares of the specialty chemicals company's stock worth $2,185,000 after purchasing an additional 23,766 shares during the period. GAMMA Investing LLC boosted its position in Chemours by 99.7% during the fourth quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company's stock valued at $26,000 after acquiring an additional 765 shares during the last quarter. Matrix Trust Co grew its holdings in Chemours by 715.7% during the 4th quarter. Matrix Trust Co now owns 9,952 shares of the specialty chemicals company's stock worth $168,000 after acquiring an additional 8,732 shares during the period. Inspire Investing LLC lifted its stake in shares of Chemours by 17.4% in the 4th quarter. Inspire Investing LLC now owns 23,799 shares of the specialty chemicals company's stock valued at $402,000 after purchasing an additional 3,523 shares during the period. Finally, KBC Group NV boosted its position in shares of Chemours by 38.2% during the 4th quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company's stock valued at $104,000 after purchasing an additional 1,708 shares in the last quarter. Institutional investors own 76.26% of the company's stock.

Chemours Stock Performance

Shares of Chemours stock traded down $0.42 during trading on Friday, reaching $12.08. The company's stock had a trading volume of 2,335,300 shares, compared to its average volume of 1,880,815. Chemours has a 52 week low of $9.33 and a 52 week high of $29.21. The firm has a market cap of $1.81 billion, a PE ratio of 21.19 and a beta of 1.76. The business's 50-day moving average price is $12.79 and its 200-day moving average price is $16.71. The company has a quick ratio of 0.92, a current ratio of 1.68 and a debt-to-equity ratio of 6.70.

Chemours (NYSE:CC - Get Free Report) last released its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The company had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.37 billion. Equities analysts forecast that Chemours will post 2.03 earnings per share for the current year.

Chemours Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 8.28%. The ex-dividend date was Friday, February 28th. Chemours's dividend payout ratio is currently 175.44%.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.